legislation: 117-hr-9559
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117-hr-9559 | 117 | hr | 9559 | Innovative Technologies Impacted by COVIDâ19 Act | Health | 2022-12-14 | 2022-12-14 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House | Rep. Schneider, Bradley Scott [D-IL-10] | IL | D | S001190 | 4 | Innovative Technologies Impacted by COVID-19 Act This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022. | 2023-08-14T15:15:23Z |